no image available Dickens & Co. "Breakthrough for GIST Patients: Sunitinib's Expedited Approval Confirmed" "A Landmark Crossover Study Reduces Risks and Delays for Patients with Gastrointestinal Stromal Tumor" Price: 20.00€